Xilio Therapeutics, Inc. (BOATS:XLO) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Daniel Lynch Other companies: SpringWorks Therapeutics Inc (Director · Since at least Sep 12, 2019); 2Seventy Bio Inc (Director · Oct 18, 2021 – Jun 13, 2023 · Past); Omega Alpha SPAC (Director · Jan 6, 2021 – Jan 6, 2021 · Past); Translate Bio Inc (Director · Jun 27, 2018 – Dec 31, 2020 · Past); Sesen Bio Inc (Director · Jun 12, 2018 – Jun 19, 2019 · Past); Surface Oncology Inc (Director · Apr 18, 2018 – Jun 10, 2020 · Past); Blueprint Medicines Corp (Director · Apr 30, 2015 – Jun 24, 2020 · Past); Eleven Biotherapeutics Inc (Director · Feb 5, 2014 – May 19, 2017 · Past); BIND Therapeutics Inc (Director · Sep 19, 2013 – Jun 9, 2015 · Past); Bluebird bio Inc (Director · Jun 18, 2013 – Nov 11, 2021 · Past) | Director · Oct 21, 2021 – Oct 21, 2021 · Past |
| Cheryl R. Blanchard Other companies: Vigil Neuroscience Inc (Director · Since at least Jan 6, 2022); Anika Therapeutics Inc. (Director · Since at least Aug 31, 2018); Dare Bioscience, Inc. (Director · Nov 20, 2019 – Jun 21, 2023 · Past); Neuronetics, Inc. (Director · Feb 13, 2019 – May 26, 2020 · Past); SeaSpine Holdings Corp (Director · Jul 1, 2015 – May 30, 2018 · Past); Zimmer Biomet Holdings, Inc. (Sr. VP, Chief Scientific Off. · Feb 17, 2011 – Mar 19, 2012 · Past) | Board Member · Since at least Apr 15, 2026 |
| Paul J. Clancy Other companies: Sionna Therapeutics, Inc. (Chair · Since at least Feb 6, 2025); EXACT Sciences Corporation (Director · Since at least Mar 18, 2021); Incyte Corporation (Director · Since at least Jan 20, 2015); Alexion Pharmaceuticals Inc (EVP, Chief Financial Officer · Jul 10, 2017 – Jul 11, 2019 · Past); Agios Pharmaceuticals, Inc. (Director · Sep 24, 2013 – Jun 21, 2022 · Past); Biogen Inc. (Executive VP and CFO · Aug 13, 2007 – Apr 25, 2017 · Past) | Director · Since at least Oct 21, 2021 |
| James Shannon Other companies: ProQR Therapeutics N.V. (Director · Since at least Mar 18, 2026); MannKind Corporation (Chairman of the Board · Since at least Jun 10, 2010); Horizon Pharma PLC (Director · Aug 2, 2017 – Aug 2, 2018 · Past); Endocyte Inc (Director · Feb 4, 2011 – May 26, 2011 · Past) | Board Member · Since at least Jun 13, 2024 |
| Aoife Brennan Other companies: Climb Bio, Inc. (President and CEO, Director · Since at least Jun 27, 2024); Kyntra Bio, Inc. (Director · May 26, 2021 – Jun 5, 2024 · Past); Synlogic Inc (President and CEO, Director · Mar 10, 2021 – Nov 10, 2023 · Past) | Director · Since at least Jun 13, 2024 |
| Martin H Huber Jr Other companies: Actuate Therapeutics, Inc. (Director · Since at least May 1, 2026); Syndax Pharmaceuticals, Inc. (Director · Since at least Sep 15, 2021); Mersana Therapeutics Inc (President, CEO, Director · Since at least Jan 15, 2021) | PRESIDENT AND HEAD OF R&D · Oct 21, 2021 – Aug 16, 2023 · Past |
| Sara Bonstein Other companies: Latigo Biotherapeutics, Inc. (Director · Since at least Aug 6, 2026); Scpharmaceuticals Inc (Director · Since at least Jun 14, 2022); Insmed Incorporated (Chief Financial Officer · Since at least May 11, 2022) | Chair of the Board · Since at least Jun 15, 2022 |
| Christina Rossi Other companies: CG Oncology, Inc. (Biopharmaceutical Executive & Board Member · Since at least Nov 24, 2025); Blueprint Medicines Corp (Chief Operating Officer · Since at least Oct 29, 2018) | Director · Since at least Oct 21, 2021 |
| Daniel J. Curran Other companies: ALX Oncology Holdings Inc. (Director · Since at least Aug 12, 2025); Catalyst Pharmaceuticals, Inc. (Director · Since at least Aug 1, 2025) | Board Member · Since at least Oct 21, 2021 |
| Rachel Humphrey Other companies: Pyxis Oncology, Inc. (Director · Since at least Aug 11, 2022); Black Diamond Therapeutics, Inc. (Chief Medical Officer · Feb 17, 2021 – Feb 17, 2021 · Past) | Director · Oct 21, 2021 – Oct 21, 2021 · Past |
| René Russo Other companies: Invivyd, Inc. (Director · Aug 5, 2021 – Aug 5, 2021 · Past); X4 Pharmaceuticals, Inc. (Director · Jun 17, 2019 – Jun 2, 2021 · Past) | President and Chief Executive Officer · Since at least Oct 21, 2021 |
| Yuan Xu Other companies: Fate Therapeutics, Inc. (Board Member · Since at least Aug 3, 2021); Akero Therapeutics Inc (Director · Since at least Apr 22, 2021) | Board Member · Since at least Jan 4, 2022 |
| Robert Ross Other companies: Obsidian Therapeutics, Inc. (Director · Since at least Aug 3, 2026) | Board Member · Since at least Jun 14, 2024 |
| Akintunde Bello | Board Member · Since at least Jun 10, 2025 |
| Ben Harshbarger | Chief Legal Officer · Since Jun 29, 2026 · Appointed, no departure found |
| Ben Harshbarger | Chief Legal Officer · Since at least Jun 29, 2026 |
| Caroline Hensley | Chief Legal Officer · Dec 16, 2024 – Nov 4, 2026 · Past |
| Chris Frankenfield | Chief Financial and Operating Officer · Since at least Nov 4, 2026 |
| Christopher James Frankenfield | Chief Financial Officer · Since at least Aug 3, 2023 |
| ContactScott Young | Vice President, Investor Relations and Corporate Communications · Feb 12, 2025 – Nov 4, 2026 · Past |
| Katarina Luptakova | CHIEF MEDICAL OFFICER · Since at least Sep 5, 2023 |
| Nathan McBride | Chief Information Officer · Since at least Nov 4, 2026 |
| Salvatore Giovine | CHIEF FINANCIAL OFFICER · Oct 21, 2021 – Feb 22, 2022 · Past |
| Scott Coleman | Chief Development Officer · Since at least Nov 4, 2026 |
| Uli Bialucha | Chief Scientific Officer · Since at least Apr 17, 2026 |
| Yariv J. Houvras | Chief Medical Officer · Since at least Sep 28, 2026 |